Evenamide
Evenamide (NW-3509) is a sodium channel modulating compound. It has demonstrated therapeutic potential in preclinical rodent models for psychiatric disorders including psychosis, mania, and depression. Its activity supports research into neuropharmacology and central nervous system drug discovery.
Product Specifications
CAS Number
1092977-61-1
Product Name Alternative
Depression, channel, aggressiveness, NW3509, NW-3509, NW 3509, Na channels, Na+ channels, inhibit, Inhibitor, Evenamide, gated, mania, VGSC, voltage, SodiumChannel, psychosis, Sodium channel, Sodium Channel, sodium, schizophrenia
Field of Research
Pharmacology & Drug Discovery
Purity
96.74% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (17.96 mM) ; DMSO:290 mg/mL (1041.7 mM)
Smiles
CCCCOc1cccc (CCNCC (=O) N (C) C) c1
Molecular Formula
C16H26N2O2
Molecular Weight
278.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6508084-01 0.1 mg
Patched 1 (PTCH, PTC, BCNS, FLJ42602, Holoprosencephaly 7, HPE7, NBCCS, Patched 1, Patched Homolog 1, Patched Protein Homolog 1, PTC1, PTCH1)
Sign In for Pricing
View Details MBS6508084-02 5x 0.1 mg
Patched 1 (PTCH, PTC, BCNS, FLJ42602, Holoprosencephaly 7, HPE7, NBCCS, Patched 1, Patched Homolog 1, Patched Protein Homolog 1, PTC1, PTCH1)
Sign In for Pricing
View Details 
